Zacks Research Estimates Exelon’s Q3 Earnings (NASDAQ:EXC)

Exelon Co. (NASDAQ:EXCFree Report) – Analysts at Zacks Research dropped their Q3 2024 earnings per share estimates for Exelon in a report released on Tuesday, October 29th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $0.67 for the quarter, down from their prior estimate of $0.68. The consensus estimate for Exelon’s current full-year earnings is $2.44 per share. Zacks Research also issued estimates for Exelon’s Q4 2024 earnings at $0.61 EPS, FY2024 earnings at $2.43 EPS, Q2 2025 earnings at $0.49 EPS, Q4 2025 earnings at $0.64 EPS, FY2025 earnings at $2.60 EPS, Q1 2026 earnings at $0.77 EPS, Q3 2026 earnings at $0.82 EPS and FY2026 earnings at $2.76 EPS.

Exelon (NASDAQ:EXCGet Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.71 EPS for the quarter, topping analysts’ consensus estimates of $0.67 by $0.04. The business had revenue of $6.15 billion for the quarter, compared to analyst estimates of $5.85 billion. Exelon had a net margin of 10.65% and a return on equity of 9.40%. Exelon’s revenue for the quarter was up 2.9% compared to the same quarter last year. During the same period last year, the firm earned $0.67 earnings per share.

EXC has been the topic of a number of other research reports. Wells Fargo & Company raised their price objective on Exelon from $40.00 to $42.00 and gave the stock an “equal weight” rating in a research note on Friday, August 2nd. Scotiabank raised their price target on Exelon from $37.00 to $40.00 and gave the stock a “sector perform” rating in a research report on Tuesday, August 20th. UBS Group upped their price objective on shares of Exelon from $40.00 to $43.00 and gave the stock a “neutral” rating in a research report on Friday, September 20th. Morgan Stanley raised their target price on shares of Exelon from $42.00 to $45.00 and gave the company an “equal weight” rating in a report on Wednesday, September 25th. Finally, Barclays boosted their target price on shares of Exelon from $41.00 to $44.00 and gave the company an “overweight” rating in a research report on Tuesday, October 15th. Eleven equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, Exelon presently has an average rating of “Hold” and a consensus target price of $41.33.

Read Our Latest Stock Analysis on Exelon

Exelon Stock Down 1.0 %

Shares of EXC opened at $39.30 on Wednesday. The company has a current ratio of 1.03, a quick ratio of 0.93 and a debt-to-equity ratio of 1.66. Exelon has a 12 month low of $33.35 and a 12 month high of $41.48. The firm’s 50 day moving average is $39.65 and its 200-day moving average is $37.70. The stock has a market capitalization of $39.32 billion, a PE ratio of 16.17, a P/E/G ratio of 2.90 and a beta of 0.53.

Exelon Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 13th. Stockholders of record on Monday, November 11th will be issued a dividend of $0.38 per share. The ex-dividend date is Friday, November 8th. This represents a $1.52 annualized dividend and a dividend yield of 3.87%. Exelon’s dividend payout ratio (DPR) is presently 62.55%.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of EXC. Crewe Advisors LLC acquired a new position in Exelon in the 1st quarter worth about $26,000. American National Bank & Trust boosted its stake in shares of Exelon by 178.8% during the third quarter. American National Bank & Trust now owns 697 shares of the company’s stock valued at $28,000 after purchasing an additional 447 shares in the last quarter. Versant Capital Management Inc grew its holdings in shares of Exelon by 646.2% during the second quarter. Versant Capital Management Inc now owns 776 shares of the company’s stock worth $27,000 after purchasing an additional 672 shares during the last quarter. J.Safra Asset Management Corp acquired a new position in shares of Exelon in the second quarter valued at approximately $28,000. Finally, Abound Wealth Management raised its holdings in Exelon by 502.7% in the 2nd quarter. Abound Wealth Management now owns 892 shares of the company’s stock valued at $31,000 after buying an additional 744 shares during the last quarter. 80.92% of the stock is currently owned by institutional investors.

About Exelon

(Get Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

Further Reading

Earnings History and Estimates for Exelon (NASDAQ:EXC)

Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.